The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
Takeda has granted Lupin non-exclusive patent licensing rights to commercialize Vonoprazan in India
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
ALS patients experience neuroinflammation and rapid neurodegeneration
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
First-in-human Phase-1 study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SUVN-I6107 in healthy subjects
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
India Business grew by 11.9% YoY to Rs. 1196.2 crore
The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity
Subscribe To Our Newsletter & Stay Updated
